<DOC>
	<DOCNO>NCT00985738</DOCNO>
	<brief_summary>The purpose study determine effect short-term intake daily Dutasteride patient prostate cancer .</brief_summary>
	<brief_title>Role Dutasteride Patients Undergoing 3D Mapping Biopsy Early Stage Prostate Cancer</brief_title>
	<detailed_description>This study men undergone standard 10 core biopsy detection prostate cancer determine prostate cancer Gleason score ≤ 7 ( low moderate risk 2-7 ) . Of men , one arm two arm randomize group administer treatment regime Dutasteride versus control group receive standard care , prior map biopsy . This proposal aim study apparent effect use Dutasteride ( 3 month ) initial tumor volume ( diagnosis ) men low volume cancer undergo 3D mapping biopsy .</detailed_description>
	<mesh_term>Prostatic Neoplasms</mesh_term>
	<mesh_term>Dutasteride</mesh_term>
	<criteria>4085 year old male Patient newly diagnose clinical Stage T1aT2c prostate cancer base transrectal guide extended prostate biopsy least 10 core . Patient elect undergo 3D map biopsy center part prostate cancer management . Patient read , understand sign inform consent agreement Patients must life expectancy least one year . Gleason score ≤ 7 ( low moderate risk 27 ) 7= 3+4 Percentage positive core rate &lt; 50 % base sextant extend biopsy technique . Prostate Volume ( PV ) &gt; 15 gram . Negative imaging study ( available ) stag period Bone scan , MRI CT scan PSA &gt; 10 ng.dl initiation study drug Any 5αreductase inhibitor medication within past 12 month enrollment . Known hypersensitivity dutasteride , 5αreductase inhibitor . Anticipated blood donation within next 90 day . Serum PSA level &gt; 20ng/dl . Clinical evidence metastatic prostate cancer . Two document urinary tract infection past year CHF , MI ( within 6 month ) symptomatic CVS disease Other serious disease ( hematological , hepatic , renal , respiratory psychiatric ) Enrollment study disease past 30 day Significant urinary incontinence Diagnosis cancer consider cure , except BCC skin Prior transurethral resection prostate large tissue defect . History abdominoperineal resection rectal cancer , rectal stenosis , major rectal pathology Previous concurrent radiotherapy , hormonal therapy chemotherapy</criteria>
	<gender>Male</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>March 2016</verification_date>
	<keyword>Prostate Cancer</keyword>
	<keyword>Early Stage Prostate Cancer</keyword>
</DOC>